Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
European Journal of Pharmacology|October 26, 2000
Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptorM D Wood, I Boyfield, D J Nash, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 1999
Heterocyclic analogues of 2-aminotetralins with high affinity and selectivity for the dopamine D3 receptorK Y Avenell, I Boyfield, M S Hadley, et al.
Journal of Medicinal Chemistry|November 1, 1986
Synthesis and antihypertensive activity of 4-(cyclic amido)-2H-1-benzopyransV A Ashwood, R E Buckingham, F Cassidy, et al.
Human Biology|December 29, 2000
Phylogenetic relationships of human populations in sub-Saharan AfricaW Weber, D J Nash, A G Motulsky, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Fused aminotetralins: novel antagonists with high selectivity for the dopamine D3 receptorK Y Avenell, I Boyfield, M C Coldwell, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2000
Novel 2,3,4,5-tetrahydro-1H-3-benzazepines with high affinity and selectivity for the dopamine D3 receptorN E Austin, K Y Avenell, I Boyfield, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2001
Design and synthesis of novel 2,3-dihydro-1H-isoindoles with high affinity and selectivity for the dopamine D3 receptorN E Austin, K Y Avenell, I Boyfield, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 1999
Novel 1,2,3,4-tetrahydroisoquinolines with high affinity and selectivity for the dopamine D3 receptorN E Austin, K Y Avenell, I Boyfield, et al.
Journal of Medicinal Chemistry|May 5, 2000
Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3, 4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D(3) receptor antagonist with high oral bioavailability and CNS penetration in the ratG Stemp, T Ashmeade, C L Branch, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2000
Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-AC Reavill, S G Taylor, M D Wood, et al.
Pageof 3